Wolff–Parkinson–White syndrome: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Orthodromic | |||
**Accessory pathway used for retrograde reentry conduction | |||
***QRS narrow, delta wave absent | |||
***May see ST depression, TWI | |||
***Rate 150-250 bpm | |||
*Antidromic | |||
**Accessory pathway used for anterograde conduction | |||
***QRS wide, delta wave present | |||
*Atrial fibrillation seen in 10-30% | |||
==Diagnosis== | ==Diagnosis== | ||
*Characteristic features not always seen on ECG | |||
#Short PR interval - <0.12sec | |||
# | ##Due to loss of normal AV node conduction delay | ||
# | #Delta wave / slurred upstroke | ||
# | ##Due to early activation of vent myocardium | ||
# | #QRS duration > 0.10 sec | ||
##Due to delta wave | |||
==DDX== | ==DDX== | ||
| Line 28: | Line 29: | ||
#tricuspid atresia | #tricuspid atresia | ||
#ebstein disease | #ebstein disease | ||
==Treatment== | |||
*Orthodromic | |||
**Treat like paroxysmal SVT | |||
***CCBs, BBs, procainamide, or adenosine | |||
***Procainamide safe irrespective of type of pathway conduction | |||
***Cardiovert (sync) if unstable | |||
***Adult: 50-100 J | |||
***Peds: 0.5- 2 J/kg | |||
*Antidromic | |||
*Procainamide 100mg q10min until disrhythmia terminated or max dose (1000mg) | |||
**Amiodarone | |||
**Cardioversion | |||
***Adult: 50-100 J | |||
***Peds: 0.5- 2 J/kg | |||
**Contraindicated: CCBs, BBs, digoxin, adenosine | |||
*Irregular tachycardia | |||
**Treat like antidromic | |||
==Disposition== | ==Disposition== | ||
Admission: | *Admission: | ||
**Cardioverted, chest pain, CHF, or electrolyte imbalance | |||
*Discharge | |||
**If easily terminated d/c w/ outpt EP study | |||
[[Category:Cards]] | [[Category:Cards]] | ||
Revision as of 20:56, 9 April 2011
Background
- Orthodromic
- Accessory pathway used for retrograde reentry conduction
- QRS narrow, delta wave absent
- May see ST depression, TWI
- Rate 150-250 bpm
- Accessory pathway used for retrograde reentry conduction
- Antidromic
- Accessory pathway used for anterograde conduction
- QRS wide, delta wave present
- Accessory pathway used for anterograde conduction
- Atrial fibrillation seen in 10-30%
Diagnosis
- Characteristic features not always seen on ECG
- Short PR interval - <0.12sec
- Due to loss of normal AV node conduction delay
- Delta wave / slurred upstroke
- Due to early activation of vent myocardium
- QRS duration > 0.10 sec
- Due to delta wave
DDX
- idiopathic
- hypertrophic cardiomyopathy
- transposition of great vesses
- endocardial fibroelastosis
- mitral valve prolapse
- tricuspid atresia
- ebstein disease
Treatment
- Orthodromic
- Treat like paroxysmal SVT
- CCBs, BBs, procainamide, or adenosine
- Procainamide safe irrespective of type of pathway conduction
- Cardiovert (sync) if unstable
- Adult: 50-100 J
- Peds: 0.5- 2 J/kg
- Treat like paroxysmal SVT
- Antidromic
- Procainamide 100mg q10min until disrhythmia terminated or max dose (1000mg)
- Amiodarone
- Cardioversion
- Adult: 50-100 J
- Peds: 0.5- 2 J/kg
- Contraindicated: CCBs, BBs, digoxin, adenosine
- Irregular tachycardia
- Treat like antidromic
Disposition
- Admission:
- Cardioverted, chest pain, CHF, or electrolyte imbalance
- Discharge
- If easily terminated d/c w/ outpt EP study
